Sichuan Huiyu Pharmaceutical Co Ltd (688553) — Working Capital to Net Assets Ratio
Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Working Capital to Net Assets ratio of 53.7% as of September 2025. Working capital of CN¥2.00 Billion (current assets of CN¥3.08 Billion minus current liabilities of CN¥1.08 Billion) is measured against net assets of CN¥3.72 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Sichuan Huiyu Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sichuan Huiyu Pharmaceutical Co Ltd Working Capital to Net Assets (2017–2024)
This chart shows how Sichuan Huiyu Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 53.7%, reflecting working capital of CN¥2.00 Billion against net assets of CN¥3.72 Billion CNY. For the complete balance sheet picture, see how large is Sichuan Huiyu Pharmaceutical Co Ltd's balance sheet.
Annual Working Capital to Net Assets for Sichuan Huiyu Pharmaceutical Co Ltd (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sichuan Huiyu Pharmaceutical Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 688553 financial resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 55.6% | CN¥2.21 Billion | CN¥3.97 Billion | CN¥3.34 Billion | CN¥1.14 Billion | ▲ +2.8 pp |
| 2023 | 52.7% | CN¥1.99 Billion | CN¥3.77 Billion | CN¥2.87 Billion | CN¥879.32 Million | ▼ -10.4 pp |
| 2022 | 63.1% | CN¥2.35 Billion | CN¥3.72 Billion | CN¥2.87 Billion | CN¥526.39 Million | ▼ -13.9 pp |
| 2021 | 77.0% | CN¥2.74 Billion | CN¥3.56 Billion | CN¥3.23 Billion | CN¥492.91 Million | ▲ +28.6 pp |
| 2020 | 48.4% | CN¥363.64 Million | CN¥751.48 Million | CN¥760.77 Million | CN¥397.12 Million | ▲ +6.1 pp |
| 2019 | 42.3% | CN¥172.78 Million | CN¥408.65 Million | CN¥554.01 Million | CN¥381.24 Million | ▼ -92.0 pp |
| 2018 | 134.2% | CN¥-202.32 Million | CN¥-150.70 Million | CN¥100.24 Million | CN¥302.55 Million | ▼ -38.4 pp |
| 2017 | 172.6% | CN¥-319.89 Million | CN¥-185.32 Million | CN¥41.21 Million | CN¥361.11 Million | — |